204 related articles for article (PubMed ID: 17196980)
1. Flexibility and variability of TIMP binding: X-ray structure of the complex between collagenase-3/MMP-13 and TIMP-2.
Maskos K; Lang R; Tschesche H; Bode W
J Mol Biol; 2007 Mar; 366(4):1222-31. PubMed ID: 17196980
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
[TBL] [Abstract][Full Text] [Related]
3. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-Rüth FX; Maskos K; Betz M; Bergner A; Huber R; Suzuki K; Yoshida N; Nagase H; Brew K; Bourenkov GP; Bartunik H; Bode W
Nature; 1997 Sep; 389(6646):77-81. PubMed ID: 9288970
[TBL] [Abstract][Full Text] [Related]
5. The N-terminus of collagenase MMP-8 determines superactivity and inhibition: a relation of structure and function analyzed by biomolecular interaction analysis.
Farr M; Pieper M; Calvete J; Tschesche H
Biochemistry; 1999 Jun; 38(22):7332-8. PubMed ID: 10353844
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution.
Tuuttila A; Morgunova E; Bergmann U; Lindqvist Y; Maskos K; Fernandez-Catalan C; Bode W; Tryggvason K; Schneider G
J Mol Biol; 1998 Dec; 284(4):1133-40. PubMed ID: 9837731
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
8. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
Nar H; Werle K; Bauer MM; Dollinger H; Jung B
J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez DE; Alonso DF; Yoshiji H; Thorgeirsson UP
Eur J Cell Biol; 1997 Oct; 74(2):111-22. PubMed ID: 9352216
[TBL] [Abstract][Full Text] [Related]
11. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
Maskos K
Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
Batra J; Soares AS; Mehner C; Radisky ES
PLoS One; 2013; 8(9):e75836. PubMed ID: 24073280
[TBL] [Abstract][Full Text] [Related]
13. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
[TBL] [Abstract][Full Text] [Related]
14. Global orientation of bound MMP-3 and N-TIMP-1 in solution via residual dipolar couplings.
Arumugam S; Van Doren SR
Biochemistry; 2003 Jul; 42(26):7950-8. PubMed ID: 12834347
[TBL] [Abstract][Full Text] [Related]
15. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K
J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928
[TBL] [Abstract][Full Text] [Related]
17. Dynamic characterisation of the netrin-like domain of human type 1 procollagen C-proteinase enhancer and comparison to the N-terminal domain of tissue inhibitor of metalloproteinases (TIMP).
Williamson RA; Panagiotidou P; Mott JD; Howard MJ
Mol Biosyst; 2008 May; 4(5):417-25. PubMed ID: 18414739
[TBL] [Abstract][Full Text] [Related]
18. Structural features of the reprolysin atrolysin C and tissue inhibitors of metalloproteinases (TIMPs) interaction.
Pinto AF; Terra RM; Guimarães JA; Kashiwagi M; Nagase H; Serrano SM; Fox JW
Biochem Biophys Res Commun; 2006 Sep; 347(3):641-8. PubMed ID: 16842758
[TBL] [Abstract][Full Text] [Related]
19. Balance between matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in the cervical mucus plug estimated by determination of free non-complexed TIMP.
Becher N; Hein M; Uldbjerg N; Danielsen CC
Reprod Biol Endocrinol; 2008 Sep; 6():45. PubMed ID: 18826601
[TBL] [Abstract][Full Text] [Related]
20. Structure of recombinant mouse collagenase-3 (MMP-13).
Botos I; Meyer E; Swanson SM; Lemaître V; Eeckhout Y; Meyer EF
J Mol Biol; 1999 Oct; 292(4):837-44. PubMed ID: 10525409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]